author-photo

Birgit Gruenberger

St John of God Health Care

18

Papers

355

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

P-034Austrian real world data in elderly and younger metastatic pancreatic cancer patients: Interim results of a multicenter non-interventional study with nab-paclitaxel/gemcitabine

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Cure in metastatic disease: how to manage and who is the right patient in colorectal cancer?

2018 Memo – Magazine of European Medical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients – AGMT_GASTRIC-3

2017 Anticancer Research
Show All
- Source
- Cite
- Save
Citations (3)
5-FU based chemotherapy with bevacizumab in synchronous metastatic colorectal cancer patients with bleeding primary tumor.

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
P-1615-FU based chemotherapy with Bevacizumab in synchronous metastatic colorectal cancer patients with bleeding primary tumor

2016 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Activity of neoadjuvant bevacizumab at the time of surgery after 6 weeks of preoperative cessation: A translational study.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Plasma disposition of capecitabine and its metabolites 5′DFCR and 5′DFUR in a standard and dose-intensified monotherapy regimen

2011 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (3)
Pharmacokinetics of Irinotecan in Combination with Biweekly Cetuximab in Patients with Advanced Colorectal Cancer

2010 Anticancer Research
Show All
- Source
- Cite
- Save
Citations (11)
Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

2010 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (198)
Doxorubicin pharmacokinetics following two different liposomal formulations (CAELYX™ vs MYOCET™) in advanced breast cancer patients.

2009 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)